Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

Compare

41.30

+4.99 (13.74%)

At close: Jan 22, 2026, 4:00 PM EST

41.20

-0.10 (-0.24%)

After-hours: Jan 22, 2026, 5:22 PM EST

Corcept Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	741.17	675.04	482.38	401.86	365.98	353.87	Upgrade
Revenue Growth (YoY)	17.92%	39.94%	20.04%	9.80%	3.42%	15.46%	Upgrade
Cost of Revenue	13.39	10.88	6.48	5.39	5.28	5.58	Upgrade
Gross Profit	727.78	664.16	475.89	396.47	360.7	348.29	Upgrade
Selling, General & Admin	401.86	280.32	184.26	152.85	122.36	105.33	Upgrade
Research & Development	260.35	246.89	184.35	130.99	113.86	114.76	Upgrade
Operating Expenses	662.21	527.21	368.61	283.84	236.22	220.09	Upgrade
Operating Income	65.57	136.95	107.28	112.63	124.48	128.2	Upgrade
Interest & Investment Income	22.94	24.54	17.28	3.56	0.53	3.4	Upgrade
Legal Settlements	-	-	-	-14	-	-	Upgrade
Pretax Income	88.51	161.49	124.56	116.19	125.01	131.6	Upgrade
Income Tax Expense	-17.6	20.28	18.42	14.77	12.49	25.59	Upgrade
Net Income	106.11	141.21	106.14	101.42	112.51	106.01	Upgrade
Preferred Dividends & Other Adjustments	1.45	1.48	0.64	0.13	-	-	Upgrade
Net Income to Common	104.66	139.73	105.5	101.29	112.51	106.01	Upgrade
Net Income Growth	-25.18%	33.04%	4.66%	-9.86%	6.13%	12.56%	Upgrade
Shares Outstanding (Basic)	104	103	104	107	116	115	Upgrade
Shares Outstanding (Diluted)	120	113	112	116	126	124	Upgrade
Shares Change (YoY)	7.55%	1.55%	-3.64%	-7.94%	1.42%	1.33%	Upgrade
EPS (Basic)	1.01	1.35	1.02	0.95	0.97	0.92	Upgrade
EPS (Diluted)	0.87	1.23	0.94	0.87	0.89	0.85	Upgrade
EPS Growth	-30.72%	30.85%	8.05%	-2.25%	4.71%	10.39%	Upgrade
Free Cash Flow	163.1	195.9	126.9	119.91	167.42	150.73	Upgrade
Free Cash Flow Per Share	1.36	1.73	1.14	1.03	1.33	1.21	Upgrade
Gross Margin	98.19%	98.39%	98.66%	98.66%	98.56%	98.42%	Upgrade
Operating Margin	8.85%	20.29%	22.24%	28.03%	34.01%	36.23%	Upgrade
Profit Margin	14.12%	20.70%	21.87%	25.20%	30.74%	29.96%	Upgrade
Free Cash Flow Margin	22.00%	29.02%	26.31%	29.84%	45.75%	42.59%	Upgrade
EBITDA	66.71	137.75	108.32	113.89	125.96	128.73	Upgrade
EBITDA Margin	9.00%	20.41%	22.46%	28.34%	34.42%	36.38%	Upgrade
D&A For EBITDA	1.14	0.8	1.04	1.26	1.48	0.53	Upgrade
EBIT	65.57	136.95	107.28	112.63	124.48	128.2	Upgrade
EBIT Margin	8.85%	20.29%	22.24%	28.03%	34.01%	36.23%	Upgrade
Effective Tax Rate	-	12.56%	14.79%	12.71%	9.99%	19.45%	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q